Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB26FWURV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,912
Award facts
- Contract value 100% obligated
- $23,911.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at approximately $23.9K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This delivery order, awarded on October 28, 2025, with completion targeted for October 29, 2025, represents a firm fixed-price procurement with no set-aside designation, indicating the vendor competed successfully in unrestricted federal procurement. The award was funded by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499.9M through December 31, 2036, authorizes DLA to issue delivery orders for an extensive range of pharmaceutical products including biologics, branded and generic prescription drugs, and medical consumables. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders positions the company as a critical supplier within the federal military medical system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FWURV?
SPE2DB26FWURV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FWURV worth?
The government has obligated $23,912 on SPE2DB26FWURV.
Is contract SPE2DB26FWURV an order under another contract?
Yes. SPE2DB26FWURV is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB26FWURV competed?
The extent of competition for SPE2DB26FWURV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award